Liquidating AtheroGenics Sells Off All Its Assets
“All of the company's noncash assets have been sold,” said Paul Ferdinands, a partner at King & Spalding LLP who represents AtheroGenics in the Chapter 11 case. “There are no material remaining assets in the bankruptcy estate other than the cash received from the sale and the cash on hand.”
According to an amended disclosure statement filed Tuesday and approved that same...
To view the full article, register now.